WHO NEEDS STEROID RECEPTOR ASSAYS?
- 20 May 1989
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 333 (8647) , 1126-1127
- https://doi.org/10.1016/s0140-6736(89)92395-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- PROSPECTIVE RANDOMISED TRIAL OF TAMOXIFEN VERSUS SURGERY IN ELDERLY PATIENTS WITH BREAST CANCERThe Lancet, 1988
- Confirmation of a prognostic index in primary breast cancerBritish Journal of Cancer, 1987
- STEROID-HORMONE RECEPTORS AND SURVIVAL AFTER FIRST RELAPSE IN BREAST CANCERThe Lancet, 1984
- Evaluation of the Pathologic and Prognostic Correlates of Estrogen Receptors in Primary Breast CancerAnnals of Surgery, 1982
- Influence and significance of certain prognostic factors on survival in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1982
- Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.BMJ, 1982
- Hormone dependency of breast cancerCancer, 1981
- Estrogen receptor: A prognostic factor in breast cancerCancer, 1981
- Estrogen receptor level and other factors in early recurrence of breast cancerInternational Journal of Cancer, 1980
- ŒSTROGEN RECEPTORS AND PROGNOSIS IN EARLY BREAST CANCERThe Lancet, 1979